공시 • Apr 21
Prevas AB to Report Q1, 2026 Results on May 05, 2026 Prevas AB announced that they will report Q1, 2026 results at 8:30 AM, Central European Standard Time on May 05, 2026 공시 • Feb 11
Prevas AB Proposes Dividend for the Year Ended December 2025 Th Board of Prevas AB proposed a dividend of SEK 4.00 per share (SEK 4.75) per share for the year ended December 2025. 공시 • Jan 28
Prevas Strengthens Customer Support with AI Assistance Prevas AB announced taking the next step by integrating AI into its operations and support services - a move that improves both delivery quality and the work environment for support staff. Prevas currently manages the operations and support of production-critical IT systems for several major industrial clients globally. To meet high demands for availability and quick response times, an AI-powered solution is being implemented. It enables rapid access to and reuse of information from previous cases, documentation, and system logs. The AI solution supports Prevas' support teams in their daily work. A large portion of information handling and documentation can be automated, reducing the need for manual searches and repetitive tasks. The AI support is not a standalone project, but a fully integrated part of Prevas' comprehensive offering in operations and system management. It is primarily used to quickly retrieve past solutions, compile information, and prioritize tasks. As the technology is integrated with more systems, its capabilities are expected to become even more powerful and adaptive. The next step is to automate more parts of the support workflow - from case intake and prioritization to AI-driven monitoring that detects anomalies before operations are affected. 공시 • Nov 04
Prevas AB, Annual General Meeting, Jan 31, 2026 Prevas AB, Annual General Meeting, Jan 31, 2026. 공시 • Jul 03
Prevas AB (OM:PREV B) completed the acquisition of 80% stake in Oim Sweden Ab. Prevas AB (OM:PREV B) signed an agreement to acquire 80% stake in Oim Sweden Ab on April 28, 2025.
The acquisition is subject to regulatory approval, which may take one to two months. The transaction is expected to be completed at the beginning of the third quarter of 2025.
Prevas AB (OM:PREV B) completed the acquisition of 80% stake in Oim Sweden Ab on April 28, 2025. Prevas has received the necessary regulatory approvals for the acquisition. The acquisition of OIM Sweden AB is expected to have a marginally positive impact on Prevas’ earnings per share in the current fiscal year. 공시 • May 15
Prevas AB Announces Dividend for the Financial Year 2024, Payable on May 21, 2025 Prevas AB Board of Directors' proposal, on a dividend of SEK 4.75 per share for the financial year 2024. The record date for the dividend was set to May 16, 2025, and the dividend is expected to be distributed by Euroclear Sweden AB on May 21, 2025. 공시 • May 05
Prevas AB to Report Q1, 2025 Results on May 06, 2025 Prevas AB announced that they will report Q1, 2025 results at 8:30 AM, Central European Standard Time on May 06, 2025 공시 • Apr 29
Prevas AB (OM:PREV B) signed an agreement to acquire 80% stake in Oim Sweden Ab. Prevas AB (OM:PREV B) signed an agreement to acquire 80% stake in Oim Sweden Ab on April 28, 2025.
The acquisition is subject to regulatory approval, which may take one to two months. The transaction is expected to be completed at the beginning of the third quarter of 2025. 공시 • Apr 11
Prevas AB Proposes Dividend, Payable on May 21, 2025 Prevas AB at its Annual General Meeting to be held on May 14, 2025, Board of Directors proposed that a dividend of SEK 4.75 per share, totaling SEK 61,204,842.50, will be paid and that the remaining available earnings of approximately SEK 167,943,121, be carried forward. The record date for the payment is proposed to be May 16, 2025, and if the Annual General Meeting decides in accordance with the proposal, the dividend is expected to be paid through Euroclear Sweden AB on May 21, 2025. 공시 • Feb 18
Biosensor Launches Enhanced Detection System for Border Controls Biosens®?900 Biosensor launched an enhanced detection system for drugs and explosive substances from the Biosensor Applications - will be introduced during the spring. The instrument has been developed, tested and certified in close cooperation with Prevas. The BIOSENS®?900 is a portable instrument that is used to detect traces of drugs and explosives. The analysis is used to confirm suspected and make it easier to continue searching for prohibited substances. The system is used by customers all over the world, above all for checking goods, containers and luggage at border controls and customs filters. The Biosens series has been on the market for more than 20 years, with the BIOSENS®?900 representing the third generation of the instrument. Prevas has long supported Biosensor Applications with the management and further development of the system's software platform, and they were also commissioned to assist with the development and launch of the new instrument model. The BIOSENS®? 900 has been updated in several areas. The system is now battery-powered and the handling of consumables has been simplified. Its size and weight have been reduced by more than 30%, and the instrument has gained an entirely new platform for electronics and mechanics. The software platform has also been adapted to support new features and future-proof production. 공시 • Feb 11
Prevas AB Proposes Dividend for the Year Ended December 2024 The board of Prevas AB proposed a dividend of SEK 4.75 per share (SEK 4.75) for the year ended December 2024. 공시 • Feb 06
Prevas AB to Report Fiscal Year 2024 Results on Feb 11, 2025 Prevas AB announced that they will report fiscal year 2024 results at 8:30 AM, Central European Standard Time on Feb 11, 2025 공시 • Nov 05
Prevas AB, Annual General Meeting, May 14, 2025 Prevas AB, Annual General Meeting, May 14, 2025.